The Metabolic Revolution: PNOĒ Aims to Democratize Human Performance Data

At first glance, the newest device from the health-tech firm PNOĒ looks like a relic from a cinematic dystopia—a sleek, form-fitting mask that straps around the back of the head, bearing a striking resemblance to the iconic headgear of the Batman villain Bane. However, beneath the intimidating aesthetic lies a benign and potentially revolutionary purpose: the democratization of clinical-grade metabolic insights.

By measuring the precise oxygen consumed and carbon dioxide exhaled during a brief, eight-minute session, the PNOĒ 2.0 system aims to transform raw respiratory data into a personalized roadmap for diet, training, and longevity. As the company prepares for its October 1 launch, it stands at the intersection of professional-grade diagnostics and the booming consumer wellness market.

The Evolution of Metabolic Testing: From Labs to Gym Floors

For over a century, metabolic testing has served as the gold standard for gauging cardiorespiratory fitness. Specifically, VO2 max—the maximum rate at which an individual can utilize oxygen during intense exercise—has long been a metric reserved for elite athletes and patients in clinical hospital settings. Historically, this required bulky, expensive "metabolic carts" and the presence of a highly trained technician to calibrate and administer the test.

This logistical hurdle has largely restricted access to these insights, leaving the average fitness enthusiast to rely on estimated data from smartwatches or generalized fitness trackers. PNOĒ, a 10-year-old startup with roots in Cambridge and current operations in Malden, Massachusetts, and Athens, Greece, has spent the last decade working to shrink this technology without sacrificing precision.

With the launch of the PNOĒ 2.0, the company is removing the “technician” barrier. Co-founder and CEO Apostolos Atsalakis envisions a world where a user can walk into a gym, put on the mask, push a single button, and sit quietly for eight minutes to receive a comprehensive health report. “That’s it. It’s that easy,” Atsalakis says. By making the test self-administered, the company is opening the door for deployment in smaller fitness studios, independent wellness centers, and even retail pharmacies.

Chronology of a Longevity Startup

The trajectory of PNOĒ reflects the rapid maturation of the "longevity" industry.

• Academic Foundations: The company began as an extension of Atsalakis’s PhD research at the University of Cambridge, where he investigated advanced sensing technologies. Fascinated by the chemical narrative hidden within human breath, he partnered with his childhood friend, Panos Papadiamantis, to turn his research into a commercial product.
• The Y Combinator Milestone: In the winter of 2019, the startup joined the Y Combinator accelerator. At the time, "longevity" was a niche academic interest rather than a mainstream industry buzzword.
• Scaling and Investment: Since its early days, PNOĒ has secured approximately $22 million in funding, including a recent $11 million round. Its cap table includes notable investors like the venture firm 50 Years and Google Maps co-founder Lars Rasmussen.
• Design Iteration: Developing a self-serve medical-grade device required a radical redesign. Collaborating with the Milan-based Design Group Italia, the team went through an extensive series of iterations to create a device that is smaller, more compact, and more reliable than its predecessor.
• Market Expansion: Today, the company employs 110 people and has reached profitability, growing at a rate of over 100% annually. It is currently scaling its presence across the United States, Europe, and via partners, into Latin America and Asia.

Supporting Data: What the Mask Actually Measures

The PNOĒ 2.0 is designed to capture 23 distinct biomarkers that offer a deeper dive into physiological efficiency than traditional blood work. While VO2 max is the headline metric—and one that Atsalakis describes as the "strongest predictor of human longevity"—the device also measures:

1. Resting Metabolic Rate (RMR): A precise calculation of how many calories the body burns at rest, providing a foundation for accurate nutritional planning.
2. Metabolic Flexibility: An assessment of how efficiently the body switches between burning fat and carbohydrates for fuel.
3. Respiratory Efficiency: Data regarding how the body manages gas exchange, which can highlight potential inefficiencies in breathing patterns or cardiovascular health.

By combining these data points, PNOĒ claims it can answer foundational questions that current wearables cannot, such as the specific caloric intake required for a person’s unique metabolism or how they should structure their training cycles for maximum adaptation.

Official Responses and Regulatory Clarity

Despite its clinical-grade hardware, PNOĒ maintains a strict boundary regarding its diagnostic capabilities. The device is not currently cleared by the U.S. Food and Drug Administration (FDA) for medical diagnostics.

"We do not provide medical recommendations," Atsalakis clarified during a recent interview. He frames the device as a piece of wellness hardware—comparable to a high-end body composition scale. "A doctor cannot prescribe medication based on our results," he notes. This distinction is vital for the company’s business model, as it keeps them in the wellness sphere while avoiding the long-term, expensive regulatory pathways required for a clinical diagnostic tool.

However, the company does not rule out future medical integration. Atsalakis acknowledges that the field of "breathomics"—the study of volatile organic compounds in breath that can signal diseases like cancer—is a rapidly evolving area of research. While he believes the company’s growing database of user metrics could eventually be used to flag health anomalies, he remains grounded in the present. "We’re not there yet," he says, estimating that full diagnostic integration is still years away.

The "Business in a Box" Strategy

PNOĒ operates on a B2B model, selling its "business in a box" package to elite fitness chains and wellness facilities. For a subscription fee ranging from $400 to over $1,000 per month, businesses receive the hardware, software, specialized training for staff, and marketing assets to promote the testing to their members.

The list of current clients reads like a "who’s who" of the high-end fitness and health world, including Equinox, the Four Seasons hotel chain, the NBA, the Mount Sinai Health System, and Restore Hyper Wellness.

The strategy behind this model is integration. By embedding the test into the onboarding process of a gym or a health spa, the facility can provide a personalized "scorecard" that serves as a baseline for the services they provide. If the data shows a client is metabolically inflexible, the gym can suggest specific types of interval training; if the RMR is lower than expected, a partner nutritionist can adjust the caloric plan.

Implications: The Future of Personalized Health

The rise of PNOĒ highlights a growing shift in how consumers view their health data. As smartwatches have introduced millions to the concept of heart rate variability and step counting, there is an increasing appetite for data that goes beyond simple movement tracking.

However, the sector is becoming crowded. Tech giants like Apple and Garmin are already estimating VO2 max through heart-rate sensors, and companies like Lumen have successfully marketed breath-analysis devices to the consumer market. PNOĒ’s challenge, and its competitive edge, lies in its insistence on professional-grade accuracy. It positions itself in the "middle ground"—more robust than a basic smartwatch, but more accessible than a hospital-based sports lab.

Addressing the Hygiene Factor

One of the most practical innovations of the 2.0 version is its modular design. Post-pandemic, consumers are highly sensitive to shared equipment. PNOĒ solved this by ensuring that the delicate electronics are easily detached from the silicone mask and head straps. This allows a gym to share the expensive sensor hardware among hundreds of members, while each individual retains their own personal, washable mask.

Looking Toward Series B

With the 2.0 version hitting the market, the company is already looking toward its next phase of growth. PNOĒ plans to raise a Series B funding round within the next six to 12 months. The objective is clear: to get the mask onto as many faces as possible.

As the wellness industry moves toward a data-driven future, the "Bane-like" mask may soon become a ubiquitous sight in high-end gyms. By turning the invisible mechanics of breath into a measurable, actionable, and shareable metric, PNOĒ is betting that the key to living longer isn’t just about moving more—it’s about understanding exactly how your body converts the air you breathe into the life you lead.